141 related articles for article (PubMed ID: 3073904)
1. Diazoxide-induced long-term hyperglycemia. I. Preservation of B-cell insulin-releasing capacity.
Gomis R; Plaza C; Malaisse WJ
Diabetes Res; 1988 Dec; 9(4):183-6. PubMed ID: 3073904
[TBL] [Abstract][Full Text] [Related]
2. Diazoxide-induced long-term hyperglycemia. II. Slackening of proinsulin conversion.
Valverde I; Alarcon C; Rovira A; Malaisse-Lagae F; Malaisse WJ
Diabetes Res; 1989 Feb; 10(2):59-62. PubMed ID: 2663320
[TBL] [Abstract][Full Text] [Related]
3. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
Leahy JL; Bumbalo LM; Chen C
Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
[TBL] [Abstract][Full Text] [Related]
4. Diazoxide unmasks glucose inhibition of insulin release by counteracting entry of Ca2+.
Bergsten P; Gylfe E; Wesslén N; Hellman B
Am J Physiol; 1988 Oct; 255(4 Pt 1):E422-7. PubMed ID: 3052102
[TBL] [Abstract][Full Text] [Related]
5. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets.
Song SH; Rhodes CJ; Veldhuis JD; Butler PC
Endocrinology; 2003 Aug; 144(8):3399-405. PubMed ID: 12865318
[TBL] [Abstract][Full Text] [Related]
6. Diazoxide infusion at excess but not at basal hyperglycemia enhances beta-cell sensitivity to glucose in vitro in neonatally streptozotocin-diabetic rats.
Sako Y; Grill VE
Metabolism; 1992 Jul; 41(7):738-43. PubMed ID: 1535679
[TBL] [Abstract][Full Text] [Related]
7. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
[No Abstract] [Full Text] [Related]
8. Biochemical aspects of the hyperglycemic action of diazoxide.
Senft G
Ann N Y Acad Sci; 1968 Apr; 150(2):242-55. PubMed ID: 4299217
[No Abstract] [Full Text] [Related]
9. Impact of uncoupling glucose stimulus from secretion on B-cell release and biosynthesis.
Sako Y; Eizirik D; Grill V
Am J Physiol; 1992 Feb; 262(2 Pt 1):E150-4. PubMed ID: 1539640
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic effects of glucose and carbachol on insulin secretion and phospholipase C activation: studies with diazoxide and atropine.
Yamazaki H; Philbrick W; Zawalich KC; Zawalich WS
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E26-E33. PubMed ID: 16105864
[TBL] [Abstract][Full Text] [Related]
11. Alterations in net glucose uptake and in the pancreatic B-cell GLUT2 transporter induced by diazoxide and by secretory stimuli.
Zhao L; Li Z; Kullin M; Borg LA; Karlsson FA
J Endocrinol; 2005 May; 185(2):291-9. PubMed ID: 15845921
[TBL] [Abstract][Full Text] [Related]
12. B-cell insensitivity in vitro: reversal by diazoxide entails more than one event in stimulus-secretion coupling.
Björklund A; Grill V
Endocrinology; 1993 Mar; 132(3):1319-28. PubMed ID: 7679978
[TBL] [Abstract][Full Text] [Related]
13. Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis.
Luo P; Chang HH; Zhou Y; Zhang S; Hwang SH; Morisseau C; Wang CY; Inscho EW; Hammock BD; Wang MH
J Pharmacol Exp Ther; 2010 Aug; 334(2):430-8. PubMed ID: 20439437
[TBL] [Abstract][Full Text] [Related]
14. Metabolic, cationic and secretory response to D-glucose in depolarized and Ca(2+)-deprived rat islets exposed to diazoxide.
Lebrun P; Antoine MH; Nguyen QA; Picton S; Malaisse WJ
Cell Calcium; 2000 Apr; 27(4):213-22. PubMed ID: 10858667
[TBL] [Abstract][Full Text] [Related]
15. [Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide].
Frerichs H; Gerber R; Creutzfeldt W
Diabetologia; 1966 Dec; 2(4):269-76. PubMed ID: 4902707
[No Abstract] [Full Text] [Related]
16. Functional rest through intensive treatment with insulin and potassium channel openers preserves residual beta-cell function and mass in acutely diabetic BB rats.
Rasmussen SB; Sørensen TS; Hansen JB; Mandrup-Poulsen T; Hornum L; Markholst H
Horm Metab Res; 2000 Jul; 32(7):294-300. PubMed ID: 10965937
[TBL] [Abstract][Full Text] [Related]
17. Improvement in insulin secretion in diabetes after diazoxide.
Greenwood RH; Mahler RF; Hales CN
Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
[TBL] [Abstract][Full Text] [Related]
18. Rescue of beta-cell exhaustion by diazoxide after the development of diabetes mellitus in rats with streptozotocin-induced diabetes.
Matsuda M; Kawasaki F; Mikami Y; Takeuchi Y; Saito M; Eto M; Kaku K
Eur J Pharmacol; 2002 Oct; 453(1):141-8. PubMed ID: 12393069
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of alloxan in mice.
Ahrén B; Sundkvist G
Int J Pancreatol; 1995 Apr; 17(2):197-201. PubMed ID: 7622942
[TBL] [Abstract][Full Text] [Related]
20. Short-term intermittent exposure to diazoxide improves functional performance of beta-cells in a high-glucose environment.
Yoshikawa H; Ma Z; Björklund A; Grill V
Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1202-8. PubMed ID: 15292032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
